https://www.selleckchem.com/pr....oducts/ac-devd-cho.h
Background Hepatocellular carcinoma (HCC) is one of the most lethal and malignant tumours worldwide. New therapeutic targets for HCC are urgently needed. CYCLOPS (copy number alterations yielding cancer liabilities owing to partial loss) genes have been noted to be associated with cancer-targeted therapies. Therefore, we intended to explore the effects of the CYCLOPS gene RBM17 on HCC oncogenesis to determine if it could be further used for targeted therapy. Methods We collected data on 12 types of cancer from the Cancer Genome Atla
Like
Comment
Share
